Evidence map›Paper›PMID 38872284›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2024

A comparative evaluation of ChatGPT 3.5 and ChatGPT 4 in responses to selected genetics questions.

Scott P McGrath, Beth A Kozel, Sara Gracefo, Nykole Sutherland, Christopher J Danford, Nephi Walton

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Disparate language and model effects on AI-based translation and recognition of genetic conditions.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Artificial intelligence in clinical genetics.European journal of human genetics : EJHG · 2025
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Scott P McGrathCITRIS Health, University of California Berkeley, Berkeley, CA 94720-1764, United States.ORCID 0000-0002-0065-726X
Beth A KozelLaboratory of Vascular and Matrix Genetics, National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD 20892, United States.ORCID 0000-0002-9757-7118
Sara GracefoIntermountain Precision Genomics, Intermountain Healthcare, St George, UT 84790-8723, United States.
Nykole SutherlandIntermountain Precision Genomics, Intermountain Healthcare, St George, UT 84790-8723, United States.
Christopher J DanfordTransplant Services, Intermountain Medical CenterMurray, UT 84107, United States.
Nephi WaltonNational Human Genome Research Institute, National Institute of Health, Bethesda, MD 20892-2152, United States.

Funding

Intramural ResearchNHLBINIH
6 · The paper itself

Abstract

objectivesTo evaluate the efficacy of ChatGPT 4 (GPT-4) in delivering genetic information about BRCA1, HFE, and MLH1, building on previous findings with ChatGPT 3.5 (GPT-3.5). To focus on assessing the utility, limitations, and ethical implications of using ChatGPT in medical settings. MATERIALS AND

methodsA structured survey was developed to assess GPT-4's clinical value. An expert panel of genetic counselors and clinical geneticists evaluated GPT-4's responses to these questions. We also performed comparative analysis with GPT-3.5, utilizing descriptive statistics and using Prism 9 for data analysis.

resultsThe findings indicate improved accuracy in GPT-4 over GPT-3.5 (P < .0001). However, notable errors in accuracy remained. The relevance of responses varied in GPT-4, but was generally favorable, with a mean in the "somewhat agree" range. There was no difference in performance by disease category. The 7-question subset of the Bot Usability Scale (BUS-15) showed no statistically significant difference between the groups but trended lower in the GPT-4 version. DISCUSSION AND

conclusionThe study underscores GPT-4's potential role in genetic education, showing notable progress yet facing challenges like outdated information and the necessity of ongoing refinement. Our results, while showing promise, emphasizes the importance of balancing technological innovation with ethical responsibility in healthcare information delivery.

Indexed as

Genetic CounselingBRCA1 ProteinGenetic TestingHemochromatosisHumansMutL Protein Homolog 1Surveys and QuestionnairesBRCA1 ProteinMLH1 protein, humanMutL Protein Homolog 1

Identifiers

PMID38872284
PMCPMC11413464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.